Trial intelligence / Profile preview

Aurase wound gel versus standard of care for venous leg ulcers

ISRCTN59816814Phase 2Completed

Sponsor
SolasCure
Start
Jan 2025
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
01

Overview

Phase 2, randomised, open-label trial in stasis ulcer and leg ulcer comparing Standard of care with Aurase Wound Gel plus standard wound care (2 arms). Primary endpoints: Frequency and severity of adverse events and Frequency and severity of reference wound-related local adverse events. Started Jan 2025; status: completed.

02

Drugs

aurase
03

Conditions

stasis ulcerleg ulcer

Beyond the preview

Go deeper on ISRCTN59816814.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN59816814.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call